The remaining 10–15% of human cancers exploit the homologous recombination pathway to elongate telomeres by a mechanism defined “Alternative Lengthening of Telomeres” (ALT) (Bryan et al, 1997; Recagni et al, 2020). This evidence concerns the gene GPT and cancer.